|
Oxidant stress
Citations 11-20 of 313 total displayed.
|
Past content
(since Jan 1999):
|
- Editorial Commentaries
A New PIXel in the Puzzle. How Increased Vascular Pressure Induces Oxidative Stress
- Ralf P. Brandes
Hypertension published September 21, 2009, doi:10.1161/HYPERTENSIONAHA.109.137984
[Abstract]
- Editorial Commentaries
Are Macrophages the Foot Soldiers in the War Waged by Aldosterone Against the Heart?
- Anne M. Dorrance
Hypertension 2009;54:451-453; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135855
[Full text]
- Editorial Commentaries
Is Resveratrol the Magic Bullet for Pulmonary Hypertension?
- Louis G. Chicoine, James A. Stewart, Jr, and Pamela A. Lucchesi
Hypertension 2009;54:473-474; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135251
[Full text]
- Original Articles
Critical Role of Apoptosis Signal-Regulating Kinase 1 in Aldosterone/Salt-Induced Cardiac Inflammation and Fibrosis
- Taishi Nakamura, Keiichiro Kataoka, Masaya Fukuda, Hisato Nako, Yoshiko Tokutomi, Yi-Fei Dong, Hidenori Ichijo, Hisao Ogawa, and Shokei Kim-Mitsuyama
Hypertension 2009;54:544-551; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135392
[Abstract]
[Full text]
- Original Articles
Aliskiren Enhances the Protective Effects of Valsartan Against Cardiovascular and Renal Injury in Endothelial Nitric Oxide Synthase–Deficient Mice
- Eiichiro Yamamoto, Keiichiro Kataoka, Yi-Fei Dong, Taishi Nakamura, Masaya Fukuda, Yoshiko Tokutomi, Shinji Matsuba, Hisato Nako, Naomi Nakagata, Takehito Kaneko, Hisao Ogawa, and Shokei Kim-Mitsuyama
Hypertension 2009;54:633-638; published online before print as doi:10.1161/HYPERTENSIONAHA.109.133884
[Abstract]
[Full text]
- Editorial Commentaries
Protein Kinase C–Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference
- Philip Wenzel, Eberhard Schulz, and Thomas Münzel
Hypertension published August 17, 2009, doi:10.1161/HYPERTENSIONAHA.109.136218
[Abstract]
- Scientific Contributions
Losartan Metabolite EXP3179 Blocks NADPH Oxidase-Mediated Superoxide Production by Inhibiting Protein Kinase C. Potential Clinical Implications in Hypertension
- Ana Fortuño, Julen Bidegain, Pablo A. Robador, José Hermida, Jacinto López-Sagaseta, Oscar Beloqui, Javier Díez, and Guillermo Zalba
Hypertension published August 17, 2009, doi:10.1161/HYPERTENSIONAHA.109.129353
[Abstract]
- Editorial Commentaries
Mitochondrial Thioredoxin: Novel Regulator for NADPH Oxidase and Angiotensin II-Induced Hypertension
- Tohru Fukai
Hypertension 2009;54:224-225; published online before print as doi:10.1161/HYPERTENSIONAHA.109.134403
[Full text]
- Editorial Commentary
Are Macrophages the Foot Soldiers in the War Waged by Aldosterone Against the Heart?
- Anne M. Dorrance
Hypertension published July 27, 2009, doi:10.1161/HYPERTENSIONAHA.109.135855
[Abstract]
- Editorial Commentary
Is Resveratrol the Magic Bullet for Pulmonary Hypertension?
- Louis G. Chicoine, James A. Stewart, Jr, and Pamela A. Lucchesi
Hypertension published July 13, 2009, doi:10.1161/HYPERTENSIONAHA.109.135251
[Abstract]
|
|
